Veterinary Vaccines Market in the US – Size, Forecast, and Competitive Landscape: Explore Zhengye Biotechnology’s US Potential

Market Outlook: Veterinary Vaccines Market in the US 2025-2029

The veterinary vaccines market in the US is driven by increasing pet ownership, the need for disease prevention in livestock, and advancements in vaccine technology, with a growing demand for both companion animal and livestock vaccines to ensure animal health and productivity. The market is expected to grow by USD 1-3 billion at a CAGR of 7%-9% between 2025 and 2029. Exact values for this market can be accessed upon purchasing the report. Key companies in this market include:

• Zoetis
• Merck Animal Health
• Boehringer Ingelheim Animal Health
• Elanco Animal Health
• Virbac

IPO Company Overview: Zhengye Biotechnology in the US veterinary vaccines market

Zhengye Biotechnology Holding Ltd recently launched its IPO on the Nasdaq Capital Market in January 2025 under the ticker symbol ZYBT, creating a new opportunity for investors. Zhengye Biotechnology is a biopharmaceutical company specializing in the research, development, and production of high-quality veterinary vaccines. With a focus on advancing animal health, Zhengye Biotechnology offers a comprehensive range of vaccines for both companion animals and livestock, addressing critical diseases and enhancing animal well-being.

Market Segmentation: How is the US veterinary vaccines market segmented?

Animal Type

• Livestock
• Companion Animals
• Others

Vaccine Type

• Inactivated Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• DNA Vaccines
• Others

Companion animals is the leading subsegment, driven by the growing pet ownership trend and increasing awareness about preventive healthcare, leading to higher demand for vaccines protecting pets from diseases like rabies, distemper, and parvovirus. Inactivated vaccines dominate this segment due to their proven safety profile and effectiveness in preventing a wide range of diseases in both companion animals and livestock, particularly in established veterinary practices.

Investment Opportunities: Why explore the US veterinary vaccines market with Technavio?

Recent developments in the US veterinary vaccines market have been significantly influenced by innovations in vaccine technologies, with an increasing focus on improving efficacy and safety profiles. Advancements in recombinant and DNA vaccines are providing new solutions for previously challenging diseases, offering targeted immunity with fewer side effects. Additionally, the growing trend of personalized medicine is influencing the development of vaccines tailored to specific breeds or individual animals, further enhancing disease prevention and treatment. Companies are increasingly incorporating biotechnological approaches, including mRNA vaccine technologies, to develop faster, more effective solutions for emerging animal diseases, reflecting the influence of human vaccine innovations.

The veterinary vaccines market is also seeing a rise in demand driven by the growing pet population and the increasing awareness of animal health in both companion animals and livestock. As pet ownership continues to rise in the US, there is heightened interest in preventative care, particularly in vaccines for common conditions like rabies, parvovirus, and respiratory diseases. On the livestock side, there is a strong push for vaccines that can help prevent zoonotic diseases and improve productivity, particularly in poultry and cattle farming. Furthermore, the industry is embracing digital tools for tracking vaccination records and enhancing compliance, offering veterinarians and pet owners more efficient ways to manage animal health. These developments are shaping the future of the veterinary vaccines market, driving innovation and meeting the evolving needs of the industry.

Market Dynamics: What factors are influencing the veterinary vaccines market in the US?

Drivers:
The veterinary vaccines market in the US is primarily driven by the increasing pet ownership and the rising demand for preventive healthcare in both companion animals and livestock. With pet owners becoming more aware of the importance of vaccinations, the market is seeing significant growth, especially for vaccines targeting common diseases in dogs, cats, and other pets. Additionally, livestock producers are investing in vaccines to prevent zoonotic diseases and enhance animal productivity, contributing to the demand for vaccines in cattle, poultry, and swine. The growing emphasis on animal welfare, alongside advancements in vaccine technology, further drives the market's expansion.

Trends:
A major trend in the US veterinary vaccines market is the increasing shift towards innovative vaccine technologies, including recombinant, mRNA, and DNA-based vaccines. These vaccines offer higher precision, faster development timelines, and improved efficacy with fewer side effects. The use of digital tools for tracking and managing animal health is also on the rise, allowing veterinarians and pet owners to monitor vaccination schedules and ensure better compliance. Another significant trend is the growing focus on zoonotic diseases, with vaccines designed to protect both animals and humans, as well as increased investments in preventative care for livestock to improve food security and animal welfare.

Opportunities:
The US veterinary vaccines market presents significant opportunities in the development of vaccines for emerging diseases and the expansion of vaccine portfolios for both companion animals and livestock. The rise in demand for personalized vaccines tailored to specific breeds or individual animals offers a promising growth area. Additionally, there is an opportunity in the growing aquaculture sector, where vaccines for fish and other aquatic animals are gaining traction. As regulatory frameworks evolve and the acceptance of innovative vaccine technologies like mRNA and DNA vaccines expands, new markets and customer bases can be targeted, creating substantial growth potential for companies in the space.

Challenges:
Despite its growth, the veterinary vaccines market in the US faces several challenges, including regulatory hurdles and the high costs associated with developing and manufacturing innovative vaccines. The approval processes for new vaccines can be lengthy and expensive, which may deter smaller companies from entering the market. Additionally, there is the challenge of vaccine resistance and the need for continuous research and development to stay ahead of mutating pathogens. Supply chain disruptions, as seen during the COVID-19 pandemic, can also impact vaccine production and distribution, potentially leading to delays or shortages. Lastly, educating pet owners and livestock producers about the importance of regular vaccinations remains a challenge in ensuring widespread adoption.

Investment Questions: Topics to consider when investing in the veterinary vaccines market in the US

What are the emerging vaccine technologies?

Advancements in recombinant, DNA, and mRNA vaccines are transforming the market. Companies are investing in or adopting these newer technologies to stay competitive.

What is the regulatory environment for veterinary vaccines?

US regulations can affect the development, approval, and marketing of veterinary vaccines. It is important to consider potential changes in regulations that could impact market growth or company profitability.

What is the competitive landscape?

Keeping an eye on leading players in the US veterinary vaccines market is key, as is considering how the company compares in terms of market share, innovation, and financial health.

What is the company’s pipeline for new products?

It is important to know whether the company has a strong pipeline of new vaccines in development, as well as the timeline for bringing these products to market, and what diseases or needs are they targeting.

For a detailed analysis of the veterinary vaccines market in the US, buy the full report

Technavio Report Insights: How Can Technavio Reports Help Investors Make Better Business Decisions?

Key Features of a Technavio Report: 

• Comprehensive Market Analysis: Provides a detailed overview of the veterinary vaccines market in the US, including market size, growth rate, segmentation, and regional analysis. 

• In-Depth Competitive Landscape: Offers insights into the competitive dynamics, market share and positioning, and product offerings of key players. 

• Future Market Trends: Identifies emerging trends and opportunities that can shape the future of the market. 

• Detailed Segmentation: Breaks down the market into various segments to help investors identify specific niches and target markets. 

• Expert Analysis: Provides expert insights and forecasts from industry analysts

FAQ

1. What are the main drivers of the veterinary vaccines market in the US?
Key drivers include the increasing pet ownership, the growing awareness of preventive healthcare, advancements in veterinary medicine, and the rising demand for disease prevention in livestock. Additionally, regulatory pressures and the need for biosecurity in agricultural operations further contribute to market growth.

2. What are the different types of veterinary vaccines available in the US?
Veterinary vaccines in the US are generally categorized into inactivated vaccines, live attenuated vaccines, recombinant vaccines, and DNA vaccines. Each type offers specific benefits, such as greater stability, targeted immunity, or reduced side effects.

3. Which sectors are the largest consumers of veterinary vaccines in the US?
The largest consumers of veterinary vaccines in the US are companion animals (such as dogs and cats) and livestock, particularly cattle, swine, and poultry. The aquaculture sector is also a growing market for veterinary vaccines as the demand for fish vaccines increases.

4. What trends are shaping the veterinary vaccines market in the US?
Emerging trends include the development of personalized vaccines for specific breeds or animals, the rise of innovative technologies like mRNA and recombinant vaccines, and the increasing use of digital tools to track and manage vaccination schedules. There is also growing attention on zoonotic diseases and vaccines that can protect both animals and humans.

5. How is the US regulatory environment affecting the veterinary vaccines market?
The regulatory environment plays a crucial role in the veterinary vaccines market, with stringent approval processes for new vaccines. The US Food and Drug Administration (FDA) and the USDA regulate vaccine production, ensuring safety, efficacy, and quality control. Changes in regulatory standards could impact vaccine development timelines and costs.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

• 2.2 Criticality of inputs and factors of differentiation
  • Overview on criticality of inputs and factors of differentiation

• 2.3 Factors of disruption
  • Overview on factors of disruption

• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market

• 3.2 Market characteristics
  • Market characteristics analysis

• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition

• 4.2 Market segment analysis
  • Market segments

• 4.3 Market size 2024

• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global Market - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Global Market - Market size and forecast 2024-2029 ($ billion)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Market 2019 - 2023
  • Historic Market Size - Data Table on Global Market 2019 - 2023 ($ billion)

• 5.2 Segment Analysis 2019 - 2023
  • Historic Market Size – Segment Analysis 2019 - 2023 ($ billion)

• 5.4 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

• 6.1 Impact of AI on the Global Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029

• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029

• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029

• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029

• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029

• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029

• 7.7 Market condition
  • Chart on market condition - Five forces 2024 and 2029

8 Market Segmentation

• 8.1 Market segments
  • Chart on Segmentation - Market share 2024-2029 (%)
  • Data Table on Segmentation - Market share 2024-2029 (%)

• 8.2 Segment Comparison
  • Chart on Comparison
  • Data Table on Comparison

• 8.3 Segment Market Opportunity
  • Market opportunity ($ billion)
  • Data Table on Market Opportunity ($ billion)

9 Customer Landscape

• 9.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Geographic Landscape

• 10.1 Geographic segmentation
  • Chart on market share by geography 2024-2029 (%)
  • Data Table on market share by geography 2024-2029 (%)

• 10.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison

• 10.3 Market opportunity by geography
  • Market opportunity by geography ($ billion)
  • Data Tables on Market opportunity by geography ($ billion)

11 Drivers, Challenges, and Opportunity/Restraints

• 11.1 Market drivers

• 11.2 Market challenges

• 11.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

• 11.4 Market opportunities/restraints

12 Competitive Landscape

• 12.1 Overview

• 12.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation

• 12.3 Landscape disruption
  • Overview on factors of disruption

• 12.4 Industry risks
  • Impact of key risks on business

13 Competitive Analysis

• 13.1 Companies profiled
  • Companies covered

• 13.2 Company ranking index
  • Company ranking index

• 13.3 Market positioning of companies
  • Matrix on companies position and classification

14 Appendix

• 14.1 Scope of the report

• 14.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist

• 14.3 Currency conversion rates for US$
  • Currency conversion rates for US$

• 14.4 Research methodology
  • Research methodology

• 14.5 Data procurement
  • Information sources

• 14.6 Data validation
  • Data validation

• 14.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing

• 14.8 Data synthesis
  • Data synthesis

• 14.9 360 degree market analysis
  • 360 degree market analysis

• 14.10 List of abbreviations
  • List of abbreviations